162 related articles for article (PubMed ID: 11328895)
1. Monocyte/mesangial cell interactions in high-glucose co-cultures.
Menè P; Caenazzo C; Pugliese F; Cinotti GA; D'Angelo A; Garbisa S; Gambaro G
Nephrol Dial Transplant; 2001 May; 16(5):913-22. PubMed ID: 11328895
[TBL] [Abstract][Full Text] [Related]
2. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
Singh R; Song RH; Alavi N; Pegoraro AA; Singh AK; Leehey DJ
Exp Nephrol; 2001; 9(4):249-57. PubMed ID: 11423724
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane signalling in human monocyte/mesangial cell co-cultures: role of cytosolic Ca(2+).
Menè P; Festuccia F; Polci R; Pugliese F; Cinotti GA
Nephrol Dial Transplant; 2002 Jan; 17(1):42-9. PubMed ID: 11773461
[TBL] [Abstract][Full Text] [Related]
4. Induction of mesangial interleukin-6 synthesis by apoptotic U937 cells and monocytes.
Heidenreich S; Sato T; Schmidt M; August C; Timmerman JJ; van Es LA; Daha MR
Kidney Int; 1997 Aug; 52(2):318-28. PubMed ID: 9263986
[TBL] [Abstract][Full Text] [Related]
5. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.
McLennan SV; Martell SK; Yue DK
Diabetes; 2002 Aug; 51(8):2612-8. PubMed ID: 12145178
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation.
Li J; Kang SW; Kim JL; Sung HY; Kwun IS; Kang YH
J Agric Food Chem; 2010 Mar; 58(5):3205-12. PubMed ID: 20146476
[TBL] [Abstract][Full Text] [Related]
7. Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background.
Fornoni A; Lenz O; Tack I; Potier M; Elliot SJ; Striker LJ; Striker GE
Transplantation; 2000 Aug; 70(4):587-93. PubMed ID: 10972214
[TBL] [Abstract][Full Text] [Related]
8. Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production.
Chana RS; Martin J; Rahman EU; Wheeler DC
Kidney Int; 2003 Mar; 63(3):889-98. PubMed ID: 12631069
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
10. Oryeongsan suppressed high glucose-induced mesangial fibrosis.
Yoon JJ; Lee YJ; Lee SM; Kang DG; Lee HS
BMC Complement Altern Med; 2015 Feb; 15():30. PubMed ID: 25880429
[TBL] [Abstract][Full Text] [Related]
11. Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy.
Min D; Lyons JG; Bonner J; Twigg SM; Yue DK; McLennan SV
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1229-37. PubMed ID: 19741020
[TBL] [Abstract][Full Text] [Related]
12. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy.
Li J; Lim SS; Lee JY; Kim JK; Kang SW; Kim JL; Kang YH
J Nutr Biochem; 2012 Apr; 23(4):320-31. PubMed ID: 21543205
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
[TBL] [Abstract][Full Text] [Related]
14. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
15. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
16. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Modified Hangqi Chifeng Decoction Containing Serum on the Expression of Col IV, MMP-2, and TIMP-2 in Glomerular Mesangial Cells Induced by LPS].
Liu HX; Zhang Y; Li P; Gao YH; Li S; Yu ZK
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):592-6. PubMed ID: 27386653
[TBL] [Abstract][Full Text] [Related]
18. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
19. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
20. Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.
Anderson SS; Wu K; Nagase H; Stettler-Stevenson WG; Kim Y; Tsilibary EC
Cell Adhes Commun; 1996 Aug; 4(2):89-101. PubMed ID: 8937745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
